These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 3189325)

  • 1. Serum IgA and the production of IgA by peripheral blood and bone marrow lymphocytes in patients with primary IgA nephropathy: evidence for the bone marrow as the source of mesangial IgA.
    van den Wall Bake AW; Daha MR; Evers-Schouten J; van Es LA
    Am J Kidney Dis; 1988 Nov; 12(5):410-4. PubMed ID: 3189325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased binding of polymeric lambda-IgA to cultured human mesangial cells in IgA nephropathy.
    Lai KN; To WY; Li PK; Leung JC
    Kidney Int; 1996 Mar; 49(3):839-45. PubMed ID: 8648928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Charge-dependent binding of polymeric IgA1 to human mesangial cells in IgA nephropathy.
    Leung JC; Tang SC; Lam MF; Chan TM; Lai KN
    Kidney Int; 2001 Jan; 59(1):277-85. PubMed ID: 11135081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The bone marrow as production site of the IgA deposited in the kidneys of patients with IgA nephropathy.
    van den Wall Bake AW; Daha MR; Radl J; Haaijman JJ; Van der Ark A; Valentijn RM; Van Es LA
    Clin Exp Immunol; 1988 May; 72(2):321-5. PubMed ID: 3409549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated production of polymeric and monomeric IgA1 by the bone marrow in IgA nephropathy.
    van den Wall Bake AW; Daha MR; Haaijman JJ; Radl J; van der Ark A; van Es LA
    Kidney Int; 1989 Jun; 35(6):1400-4. PubMed ID: 2770118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunopathogenesis of IgAN.
    Barratt J; Smith AC; Molyneux K; Feehally J
    Semin Immunopathol; 2007 Nov; 29(4):427-43. PubMed ID: 17851660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Light-chain composition of serum IgA1 and in vitro IgA1 production in IgA nephropathy.
    Chen N; Nusbaum P; Halbwachs-Mecarelli L; Lesavre P
    Nephrol Dial Transplant; 1991; 6(11):846-50. PubMed ID: 1775249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycosylation and size of IgA1 are essential for interaction with mesangial transferrin receptor in IgA nephropathy.
    Moura IC; Arcos-Fajardo M; Sadaka C; Leroy V; Benhamou M; Novak J; Vrtovsnik F; Haddad E; Chintalacharuvu KR; Monteiro RC
    J Am Soc Nephrol; 2004 Mar; 15(3):622-34. PubMed ID: 14978164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engagement of transferrin receptor by polymeric IgA1: evidence for a positive feedback loop involving increased receptor expression and mesangial cell proliferation in IgA nephropathy.
    Moura IC; Arcos-Fajardo M; Gdoura A; Leroy V; Sadaka C; Mahlaoui N; Lepelletier Y; Vrtovsnik F; Haddad E; Benhamou M; Monteiro RC
    J Am Soc Nephrol; 2005 Sep; 16(9):2667-76. PubMed ID: 15987753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased sialylation of polymeric immunoglobulin A1: mechanism of selective glomerular deposition in immunoglobulin A nephropathy?
    Leung JC; Poon PY; Lai KN
    J Lab Clin Med; 1999 Feb; 133(2):152-60. PubMed ID: 9989767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural features of IgA molecules which contribute to IgA nephropathy.
    Feehally J; Allen AC
    J Nephrol; 1999; 12(2):59-65. PubMed ID: 10378660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding capacity and pathophysiological effects of IgA1 from patients with IgA nephropathy on human glomerular mesangial cells.
    Wang Y; Zhao MH; Zhang YK; Li XM; Wang HY
    Clin Exp Immunol; 2004 Apr; 136(1):168-75. PubMed ID: 15030528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesangial IgA2 deposits and lectin pathway-mediated complement activation in IgA glomerulonephritis.
    Hisano S; Matsushita M; Fujita T; Endo Y; Takebayashi S
    Am J Kidney Dis; 2001 Nov; 38(5):1082-8. PubMed ID: 11684563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased cytokine-induced IgA subclass production by CD40-ligated circulating B cells in primary IgA nephropathy.
    de Fijter JW; van Nisselrooij NI; Schroeijers WE; Daha MR; van Es LA; van Kooten C
    Nephrol Dial Transplant; 1998 Feb; 13(2):285-92. PubMed ID: 9509436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant glycosylation of IgA1 and anti-glycan antibodies in IgA nephropathy: role of mucosal immune system.
    Novak J; Moldoveanu Z; Julian BA; Raska M; Wyatt RJ; Suzuki Y; Tomino Y; Gharavi AG; Mestecky J; Suzuki H
    Adv Otorhinolaryngol; 2011; 72():60-3. PubMed ID: 21865691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum levels and in vitro production of IgA subclasses in patients with primary IgA nephropathy.
    van den Wall Bake AW; Daha MR; van der Ark A; Hiemstra PS; Radl J; van Es LA
    Clin Exp Immunol; 1988 Oct; 74(1):115-20. PubMed ID: 3219797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IgA production and tonsillar focal infection in IgA nephropathy.
    Meng H; Ohtake H; Ishida A; Ohta N; Kakehata S; Yamakawa M
    J Clin Exp Hematop; 2012; 52(3):161-70. PubMed ID: 23269075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective elevation of monomeric IgA1 in IgA nephropathy patients with normal renal function.
    Peterman JH; Julian BA; Kirk KA; Jackson S
    Am J Kidney Dis; 1991 Sep; 18(3):313-9. PubMed ID: 1882822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunopathogenetic aspects of IgA nephropathy.
    van den Wall Bake AW; Daha MR; van Es LA
    Nephrologie; 1989; 10(3):141-5. PubMed ID: 2691911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenetic significance of aberrant glycosylation of IgA1 in IgA nephropathy.
    Narita I; Gejyo F
    Clin Exp Nephrol; 2008 Oct; 12(5):332-338. PubMed ID: 18404247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.